Previous Close | 132.65 |
Open | 132.45 |
Bid | 127.86 x 400 |
Ask | 129.00 x 300 |
Day's Range | 128.06 - 132.96 |
52 Week Range | 36.42 - 132.96 |
Volume | |
Avg. Volume | 905,560 |
Market Cap | 4.229B |
Beta (5Y Monthly) | 1.98 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.35 |
Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 119.20 |
Zacks.com users have recently been watching TransMedics (TMDX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
TransMedics Group, Inc. (NASDAQ:TMDX) Q1 2024 Earnings Call Transcript May 1, 2024 TransMedics Group, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the TransMedics First Quarter 2024 Earnings Conference Call. At this time, all […]
TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.